Corbus Pharmaceuticals(CRBP) - 2024 Q1 - Quarterly Report

During the three months ended March 31, 2024 and 2023, the Company issued 142,857 and 0 shares of common stock in a conversion pursuant to the K2HV Amended Loan and Security Agreement, respectively. No warrants were exercised during the three months ended March 31, 2024 and 2023. In accordance with the terms of the 2014 Plan, and pursuant to the annual evergreen provision contained in the 2014 Plan, effective as of January 1, 2023, the number of shares of common stock available for issuance under the 2014 P ...